These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31758460)

  • 21. Epidemiology, pathophysiology, and the future of ocular toxoplasmosis.
    Kijlstra A; Petersen E
    Ocul Immunol Inflamm; 2014 Apr; 22(2):138-47. PubMed ID: 24131274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular toxoplasmosis signs in mice embryo.
    Tedesco RC; Vitor RW; Brandão GP; Calabrese KS
    Micron; 2007; 38(7):729-33. PubMed ID: 17596951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular toxoplasmosis I: parasitology, epidemiology and public health.
    Furtado JM; Winthrop KL; Butler NJ; Smith JR
    Clin Exp Ophthalmol; 2013; 41(1):82-94. PubMed ID: 22594908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye.
    Norose K; Mun HS; Aosai F; Chen M; Piao LX; Kobayashi M; Iwakura Y; Yano A
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4375-81. PubMed ID: 14507882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific IgM, IgG and IgG1 directed against Toxoplasma gondii detected by flow cytometry and their potential as serologic tools to support clinical indirect fundoscopic presumed diagnosis of ocular disease.
    Martins LM; Rangel ALP; Peixe RG; Silva-Dos-Santos PP; Lemos EM; Martins-Filho OA; Bahia-Oliveira LMG
    J Immunol Methods; 2015 Feb; 417():97-106. PubMed ID: 25527345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of ocular toxoplasmosis in anti-interferon gamma treated mice.
    Olle P; Bessieres MH; Malecaze F; Seguela JP
    Curr Eye Res; 1996 Jul; 15(7):701-7. PubMed ID: 8670776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model.
    Norouzpour Deilami K; Daryani A; Ahmadpour E; Sharif M; Dadimoghaddam Y; Sarvi S; Alizadeh A
    Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):369-74. PubMed ID: 25467037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Models of Ocular Infection with Toxoplasma Gondii.
    Dukaczewska A; Tedesco R; Liesenfeld O
    Eur J Microbiol Immunol (Bp); 2015 Dec; 5(4):293-305. PubMed ID: 26716018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The causes of tissue damage in toxoplasmic retinochoroiditis.
    Dutton GN
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():404-12. PubMed ID: 3538518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis.
    Ronday MJ; Ongkosuwito JV; Rothova A; Kijlstra A
    Am J Ophthalmol; 1999 Mar; 127(3):294-300. PubMed ID: 10088739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology of Toxoplasma cysts in the retina.
    McMenamin PG; Dutton GN; Hay J; Cameron S
    Exp Eye Res; 1986 Oct; 43(4):529-43. PubMed ID: 3792458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis.
    Silveira C; Vallochi AL; Rodrigues da Silva U; Muccioli C; Holland GN; Nussenblatt RB; Belfort R; Rizzo LV
    Br J Ophthalmol; 2011 Mar; 95(3):396-400. PubMed ID: 20601663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the choroidoretinal interface by toxoplasma.
    Tabbara KF
    Eye (Lond); 1990; 4 ( Pt 2)():366-73. PubMed ID: 2199243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.
    Lu F; Huang S; Kasper LH
    Infect Immun; 2004 Sep; 72(9):4966-72. PubMed ID: 15321988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
    Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
    Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New trends in ocular toxoplasmosis--the review].
    Borkowski PK
    Przegl Epidemiol; 2001; 55(4):483-93. PubMed ID: 11921736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphometric changes in C57BL/6 mice retina infected by Toxoplasma gondii ME 49 strain.
    Rocha AC; Calabrese Kda S; Tedesco RC; Campos WR; Neto MH; Vasconcelos AC; Oréfice F
    Exp Parasitol; 2014 Jan; 136():1-4. PubMed ID: 24211418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Toxoplasma gondii Infection Rates for Retinas from Eye Banks, Southern Brazil.
    Commodaro AG; Chiasson M; Sundar N; Rizzo LV; Belfort R; Grigg ME
    Emerg Infect Dis; 2016 Apr; 22(4):691-3. PubMed ID: 26982526
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Zhang Y; Zhang Q; Li H; Cong H; Qu Y
    Front Cell Infect Microbiol; 2022; 12():1002817. PubMed ID: 36171756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis.
    Feron EJ; Klaren VN; Wierenga EA; Verjans GM; Kijlstra A
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3228-32. PubMed ID: 11726627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.